Johnson Andrea M, Argenta Peter A
Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, United States.
Division Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN 55455, United States.
Gynecol Oncol Rep. 2023 Aug 23;49:101264. doi: 10.1016/j.gore.2023.101264. eCollection 2023 Oct.
•Primary angiosarcoma of the ovary historically has no standard treatment due to its rarity, and outcomes have been variable.•Olaparib may represent a viable treatment option for primary angiosarcoma of the ovary with a somatic BRCA mutation.•Next-generation sequencing may play an important component in treatment of very rare cancers to guide new or uncommon therapies.
•由于卵巢原发性血管肉瘤罕见，历史上一直没有标准治疗方法，治疗结果也各不相同。
•奥拉帕尼可能是治疗伴有体细胞BRCA突变的卵巢原发性血管肉瘤的一种可行治疗选择。
•新一代测序可能在极罕见癌症的治疗中发挥重要作用，以指导新的或不常见的治疗方法。
